There wasn't from the company's standpoint. From the company's standpoint, it was part of the agreement that they would be transferring that technology to Canada.
Professor of Pediatrics and Microbiology & Immunology, Dalhousie University and Director, Canadian Center for Vaccinology, As an Individual
There wasn't from the company's standpoint. From the company's standpoint, it was part of the agreement that they would be transferring that technology to Canada.
See context to find out what was said next.